Chemours Appoints Tony Satterthwaite to Board

Chemours Company, a global leader in titanium technologies, thermal & specialized solutions, and advanced performance materials, has appointed Livingston "Tony" Satterthwaite to its board of directors, effective June 12, 2024. Tony brings extensive leadership and board experience, having served as the Senior Vice President at Cummins, Inc. He will retire from Cummins in September 2024, after a 36-year tenure.

Chemours President and CEO Denise Dignam expressed confidence in Tony's expertise and insights, emphasizing the value he will bring to the board. With an MBA from Stanford University and an undergraduate degree in civil engineering from Cornell University, Tony also serves on the board of directors for IDEX Corporation, the National Association of Manufacturers, and the Cummins Foundation, in addition to being an industrial advisory council member for Amprius, Inc.

Chemours, with approximately 6,200 employees and 28 manufacturing sites, serves around 2,700 customers in approximately 110 countries. The company's flagship products, sold under prominent brands like Ti-Pure™, Opteon™, and Teflon™, cater to various industries including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Chemours is listed on the NYSE under the symbol CC.

It's noteworthy that Chemours has seen a 10% increase in its customer base since the last period, with a significant expansion in its market reach to approximately 110 countries. Additionally, the company's workforce has grown by 8% over the same period, now standing at approximately 6,200 employees. The market has reacted to these announcements by moving the company's shares 5.4% to a price of $25.56. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.